Menu ×

HEALTHCARE & PHARMACEUTICAL

Cardiac Implants Market Segmentation by Product (Coronary, Implantable Cardioverter-Defibrillators, Heart Rhythm Monitors, Hemodynamic Monitors, and Pacemakers); by Material (Alloys, Biological, Metals, and Polymers); by Procedure (Angioplasty, and Open-Heart Surgery); by Application (Acute Myocardial Infarction, Myocardial Ischemia, and Arrhythmias); and by End-User (Cardiology Centers, Clinics, Hospitals, and Others) – Global Demand Analysis & Opportunity Outlook 2031

  • Text Size:

Extensive insights into the Growth of Cardiac Implants Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


IN THE NEWS

  • April 28, 2022: Boston Scientific Corporation acquires clearance from U.S. Food and Drug Administration (FDA) for its EMBOLD Fibered Detachable Coil that decreases the rate of peripheral vasculature blood flow.

  • April 26, 2022:  BIOTRONIK, Inc. to receive approval of Renamic New, a software programmer for cardiac rhythm management devices, from the U.S. Food and Drug Administration (FDA).

Global Cardiac Implants Market Highlights Over 2022 - 2031

The global cardiac implants market is estimated to garner noteworthy revenue by growing at a CAGR of ~10% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the higher prevalence of cardiovascular disorders and heart diseases worldwide. Furthermore, escalating administrative approval for cardiac implants is also projected to propel the growth of the market during the forecast period. Cardiovascular diseases are one of the major causes of death worldwide.  As per a report published by World Health Organization (WHO), about 17.9 million people lost their lives in 2019 due to CVDs across the globe which was 32% of entire global deaths. Furthermore, another data released by American Heart Association demonstrated that about 90% of people encounter out-of-hospital cardiac arrest which results in death. Cardiac implants are developed and utilized to monitor misbalanced heartbeats, heart rhythm disorders, heart failure, coronary artery diseases, myocardial, infarction, and others. These are the prime factors to drive the growth of the market over the forecast period.

Cardiac Implants Market

Get more information on this report: Request Sample PDF

The market is segmented by procedure into angioplasty, and open-heart surgery, out of which, the angioplasty segment is anticipated to hold a notable share in the global cardiac implants market. The growth of the segment is ascribed to the effectiveness and accuracy of the procedure and the growing geriatric population. Angioplasty is a procedure in which the narrowed arteries are opened up by using a particular tool such as, a catheter.

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita, (USD), 2015-2018

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Cardiac Implants Market Regional Synopsis

Regionally, the global cardiac implants market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the North America region is estimated to witness noteworthy growth over the forecast period on account of a higher prevalence of death due to CVDs. Other major factors to hike the growth of the market include the increasing geriatric population and higher consumption of cigarettes in the region. Data published by Diseases Control and Prevention (CDC), demonstrated that 3,800 younger people in the USA start smoking cigarettes every day. Furthermore, Heart diseases are the most common reason for death in North America. Based on another report published by the Centers for Diseases Control and Prevention (CDC), in 2019, 659,000 people lost their lives due to heart diseases solely in the USA while the number of annual deaths is 805,000.

Furthermore, the global cardiac implants market is projected to grow at a significant pace in the Asia Pacific region over the forecast period on the back of similar factors such as, the growing geriatric population and the rising prevalence of heart diseases in the region. Based on a report by Asian Development Bank (ADB), the geriatric population in the region is estimated to reach approximately 923 million by the middle of this century.

Cardiac Implants Market Share

Get more information on this report: Request Sample PDF

The global cardiac implants market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook

  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook

  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of the Middle East and Africa) Market size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global cardiac implants market includes the following segments:

By Product

  • Coronary
  • Implantable Cardioverter-Defibrillators
  • Heart Rhythm Monitors
  • Hemodynamic Monitors
  • Pacemakers

By Material

  • Alloys
  • Biological
  • Metals
  • Polymers

By Procedure

  • Angioplasty
  • Open-Heart Surgery

By Application

  • Acute Myocardial Infarction
  • Myocardial Ischemia
  • Arrhythmias

By End-User

  • Cardiology Centers
  • Clinics
  • Hospitals
  • Others

Growth Drivers

  • Rising Prevalence of Cardiovascular Disorders and Heart Diseases
  • Growing Consumption of Cigarettes
  • Increasing Geriatric Population

Challenges

  • Infection Due to Implantable Pacemaker in Patient

Top Featured Companies Dominating the Market

  • Boston Scientific Corporation
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • BIOTRONIK SE & Co., KG
  • ZOLL Medical Corporation
  • Medtronic plc
  • LivaNova PLC
  • Abbott Laboratories 
  • MEDICO S.R.L.
  • Lepu Medical Technology Co., Ltd.
  • Cook Group Incorporated
  • Shree Pacetronix Ltd.

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved